
Journal of Medicinal Chemistry p. 1363 - 1368 (1988)
Update date:2022-07-30
Topics:
Kanojia, Ramesh M.
Press, Jeffery B.
Lever, O. William
Williams, Louella
McNally, James J.
et al.
A series of isoquinolin-3-ol derivatives (II) was prepared as analogues of the clinical cardiotonic agent bemarinone (ORF 16600,I).Although in many respects the structural requirements for the cardiotonic activity of II are similarto those of bemarinone, ceratin differences between the series were noted.Our structure-activity studies show that II is less sensitive to alkoxy-substitution effects than is I, and more significantly, 4-substitution of II by alkyl groups, halogen, or alkanecarboxylic acid derivatives enhances cardiotonic activity in II in contrast to I, wherein analogous substitution eliminated activity.A linear correlation between contractile force (CF) increase and cyclic nucleotide phosphodiesterase fraction III (PDE-III) inhibition by the title compounds was determined.The isoquinoline derivatives were characteristically short-acting cardiotonic agents with good potency and selectivity.
View MoreNanjing Legend Pharmaceutical & Chemical Co., Ltd.
Contact:+86-25-83767696
Address:14-7 Zhongshan Lu Guluo District, Nanjing
Zhejiang Golden-Shell Pharmaceutical Co.,Ltd.
Contact:+86-576-87501888 / 87501988
Address:No.89 Zhongxing Road. Li'ao, Yuhuan, Zhejiang, China
Jiangsu Allyrise Pharmaceutical Co., Ltd.(expird)
Contact:+86-523-86818997
Address:Taizhou,Jiangsu Province,CHINA
Guangzhou Chemical Reagent Factory
Contact:+86-20-8435 9820 or 8435 7345
Address:Southern Guangzhou, Guangdong, China
Contact:86-513-84128750/13773795976
Address:No.48.Youyi West Road ,Rudong Development Zone,Jiangsu Province,China
Doi:10.1021/ja01123a004
(1952)Doi:10.1021/om9906316
(1999)Doi:10.1016/S0040-4020(99)00805-4
(1999)Doi:10.1021/ol9908272
(1999)Doi:10.1016/S0040-4039(99)01494-X
(1999)Doi:10.1021/jo991299a
(1999)